Table 2 Differences in serum PDGF isoform concentrations and plasma SOD isoenzyme activities between EOS patients and HCs.
Variable | Patients (n = 99) | HCs (n = 40) | F | P | q value |
|---|---|---|---|---|---|
PDGF-AB (ng/mL) | 1.19 ± 0.46 | 1.58 ± 0.60 | 16.050 | <0.001 | <0.001 |
*Log PDGF-BB (pg/mL) | 3.62 ± 0.27 | 3.83 ± 0.23 | 18.195 | <0.001 | <0.001 |
PDGF-CC (ng/mL) | 3.86 ± 1.54 | 4.08 ± 1.14 | 0.441 | 0.508 | 0.711 |
PDGF-DD (ng/mL) | 0.55 ± 0.25 | 0.55 ± 0.26 | 0.035 | 0.852 | 0.852 |
T-SOD (U/mL) | 58.07 ± 5.17 | 61.69 ± 8.16 | 9.037 | 0.003 | 0.005 |
CuZn-SOD (U/mL) | 31.47 ± 4.48 | 31.82 ± 4.57 | 0.053 | 0.818 | 0.852 |
Mn-SOD (U/mL) | 26.60 ± 4.55 | 29.86 ± 5.26 | 13.419 | <0.001 | <0.001 |